DNA fingerprints provide a patient-specific breast cancer marker

Annals of Surgical Oncology

Volumn 11, Issue 6, 2004, Pages 560-567

  Toth Fejel, Suellen ^a   Muller, Patrick ^a   Ham, Bruce ^a   Esvelt, Kevin ^a   Dumas, Nicole ^a   Calhoun, Kristine ^a   Pommier, Rodney ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Section of Surgical Oncology   (United States)

Author keywords

Alu PCR; Breast cancer; DNA fingerprinting; Tumor markers

Indexed keywords

TUMOR MARKER;

ALU SEQUENCE; ARTICLE; AXILLARY LYMPH NODE; BLOOD SAMPLING; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DNA EXTRACTION; DNA FINGERPRINTING; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENOME ANALYSIS; HUMAN; LABORATORY DIAGNOSIS; POLYMERASE CHAIN REACTION; BREAST TUMOR; CASE CONTROL STUDY; GENETICS; PATHOLOGY; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

ALU ELEMENTS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA FINGERPRINTING; FEMALE; HUMANS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 4043079043     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.03.049     Document Type: Article

References (17)

1. Nemoto T, Natarajan N, Bedwani R, Vana J, Murphy GP. Breast cancer in the medial half: results of the 1978 national survey of the American College of Surgeons. Cancer 1983;51:1333-8.
2. Bergstein I. Molecular alterations in breast cancer. In: Bowcock, AM, eds. Breast Cancer. Totowa, Humana Press, 1999.
3. Heim S, Mitelman F. Tumors of the breast. In: Heim S, Mitelman F, eds. Cancer Cytogenetics, 2nd ed. New York: Wiley-Liss, 1985;369-88.
4. Pandis N, Heim S, Brardi G, Idvall I, Mandahl N, Mitelman F. Chromosome analysis of 20 breast carcinomas: Cytogenetic multiclonality and karyotypic-pathologic correlations. Genes Chrom Cancer 1993;6:51-7.
5. Marchetti A, Buttitta F, Bertacca G, et al. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. J Pathol 2001;95:186-90.
6. Taback B, Chan A, Kuo C, et al. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res 2001;61:8845-50.
7. Gion M, Mione R, Leon AE, et al. CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases. Euro J Cancer 2001;37:355-63.
8. Gal S, Fidler C, Dennis L, et al. Detection of mammaglobin mRNA in the plasma of breast cancer patients. Ann NY Acad Sci 2001;945:192-4.
9. Roy A, Carroll M, Nguyen S, et al. Potential gene conversion and source genes for recently integrated Alu Elements. Genome Research 2000;10:1485-95.
10. Sinnett D, Deragon JM, Simard LR, Labud D. Alumorphs: human DNA polymorphisms detected by polymerase chain reaction using Alu-specific primers. Genomics 1990;7:331-3.
11. Zietkiewicz E, Labuda M, Sinnett D, Glorieux FH, Labuda D. Linkage mapping by simultaneous screening of multiple polymorphic loci using Alu oligonucleotide-directed PCR. Proc Natl Acad Sci USA 1992;89:8448-51.
12. McKie AB, Iwamura T, Leung HY, Hollingsworth MA, Lemoine NR. Alu-polymerase chain reaction genomic fingerprinting technique identifies multiple genetic loci associated with pancreatic tumourigenesis. Genes Chromosom Cancer 1997;18:30-41.
13. Krajinovic M, Richer C, Labuda D, Sinnett D. Detection of a mutator phenotype in cancer cells in inter-Alu polymerase chain reaction. Cancer Res 1996;56:2733-7.
14. Miki Y, Katagiri T, Kasumi F, Yoshimoto T, Nakamura Y. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat Genet 1996;13:245-7.
15. American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 1996;14:671-9.
16. Naser I, Lee A, Bosari S, Saganich R, Heatley G, Silverman M. Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 1993;24:950-7.
17. Masuda N, Tomaki Y, Sakita I, et al. Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription- polymerase chain reaction in breast cancer patients. Clin Cancer Res 2000;6:4176-85.